Surgery Partners Inc Cash Flow Conversion Efficiency
Surgery Partners Inc cash flow conversion efficiency. Based on the latest financial reports, Surgery Partners Inc (SGRY) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($83.60 Million) by net assets ($3.55 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Surgery Partners Inc (2013–2024)
Cash flow conversion efficiency of Surgery Partners Inc from 2013 to 2024. This chart illustrates how Surgery Partners Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Surgery Partners Inc for real-time trading data and today's change.
Surgery Partners Inc Cash Flow Conversion Ratio Explained
Surgery Partners Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Surgery Partners Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Surgery Partners Inc ranked by their cash flow conversion efficiency. Also see SGRY stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BeiJing DaHao Technology Co Lt
SHG:603025
|
0.051x |
|
Visteon Corp
NASDAQ:VC
|
0.071x |
|
Karooooo Ltd
NASDAQ:KARO
|
0.148x |
|
MVV Energie AG
F:MVV1
|
-0.071x |
|
Olin Corporation
NYSE:OLN
|
0.160x |
|
Glodon Software Co Ltd
SHE:002410
|
0.193x |
|
Jiangsu Leili Motor Corp Ltd
SHE:300660
|
0.022x |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
0.055x |
Annual Cash Flow Conversion Efficiency for Surgery Partners Inc (2013–2024)
The table below shows the annual cash flow conversion efficiency of Surgery Partners Inc from 2013 to 2024. Review Surgery Partners Inc (SGRY) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $3.64 Billion | $300.10 Million | 0.083x | -5.54% |
| 2023-12-31 | $3.36 Billion | $293.80 Million | 0.087x | +80.67% |
| 2022-12-31 | $3.28 Billion | $158.80 Million | 0.048x | +27.72% |
| 2021-12-31 | $2.30 Billion | $87.10 Million | 0.038x | -75.10% |
| 2020-12-31 | $1.62 Billion | $246.90 Million | 0.152x | +99.58% |
| 2019-12-31 | $1.70 Billion | $129.50 Million | 0.076x | -- |
| 2018-12-31 | $0.00 | $144.60 Million | x | -- |
| 2017-12-31 | $0.00 | $120.94 Million | x | -- |
| 2016-12-31 | $0.00 | $125.24 Million | x | -- |
| 2015-12-31 | $0.00 | $84.48 Million | x | -- |
| 2014-12-31 | $222.12 Million | $21.95 Million | 0.099x | +102.89% |
| 2013-12-31 | $-14.38 Million | $49.08 Million | -3.414x | -- |
About Surgery Partners Inc
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers … Read more